Diazepam protects against rat hippocampal neuronal cell death induced by antisense oligodeoxynucleotide to GABA(A) receptor γ 2 subunit

Brain Research

Volumn 765, Issue 1, 1997, Pages 21-29

  Karle, Jesper ^a   Witt, Michael Robin ^a   Nielsen, Mogens ^a  

^a Sct Hans Hospital   (Denmark)

Author keywords

2 subunit; Antisense oligodeoxynucleotide; Diazepam; GABA(A) receptor; Radioligand binding; Rat hippocampus

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANTISENSE OLIGODEOXYNUCLEOTIDE; DIAZEPAM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CELL DEATH; GENE REPRESSION; HIPPOCAMPUS; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL DEATH; DIAZEPAM; FLUNITRAZEPAM; GABA MODULATORS; HIPPOCAMPUS; MALE; MUSCARINIC ANTAGONISTS; NERVE DEGENERATION; OLIGONUCLEOTIDES, ANTISENSE; QUINUCLIDINYL BENZILATE; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, GABA-A; RECEPTORS, MUSCARINIC; TIME FACTORS;

EID: 0030772578     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00463-0     Document Type: Article

References (53)

1. Bagetta G., Corasaniti M.T., Nisticò G., Bowery N.G. Behavioural and neuropathological effects produced by tetanus toxin injected into the hippocampus of rats. Neuropharmacology. 29:1990;765-770.
2. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 14:1985;375-403.
3. Britton P., Whitton P.S., Fowler L.J., Bowery N.G. Tetanus toxin-induced effects on extracellular amino acid levels in rat hippocampus: an in vivo microdialysis study. J. Neurochem. 67:1996;324-329.
4. Bræstrup C., Nielsen M., Squires R.F. No changes in rat benzodiazepine receptors after withdrawal from continuous treatment with lorazepam and diazepam. Life Sci. 24:1979;347-350.
5. Campbell J.M., Bacon T.A., Wickstrom E. Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid. J. Biochem. Biophys. Methods. 20:1990;259-267.
6. Chiasson B.J., Armstrong J.N., Hooper M.L., Murphy P.R., Robertson H.A. The application of antisense oligonucleotide technology to the brain: some pitfalls. Cell. Mol. Neurobiol. 14:1994;507-521.
7. Crooke S.T. Progress toward oligonucleotide therapeutics: pharmacodynamic properties. FASEB J. 7:1993;533-539.
8. 3H-diazepam in rat brain following chronic diazepam administration. Cell Biol. Int. Rep. 3:1979;163-167.
9. Farrant M., Gibbs T.T., Farb D.H. Molecular and cellular mechanisms of GABA/benzodiazepine-receptor regulation: electrophysiological and biochemical studies. Neurochem. Res. 15:1990;175-191.
10. French E.D., Aldinio C., Schwarcz R. Intrahippocampal kainic acid, seizures and local neuronal degeneration: relationships assessed in unanesthetized rats. Neuroscience. 7:1982;2525-2536.
11. A receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359:1995;154-194.
12. Gallager D.W., Lakoski J.M., Gonsales S.F., Rauch S.L. Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity. Nature. 308:1984;74-77.
13. GCG, Program Manual for the Wisconsin Package, Genetics Computer Group, Madison, WI, 1994.
14. Ghosh M.K., Cohen J.S. Oligodeoxynucleotides as antisense inhibitors of gene expression. Prog. Nucleic Acid Res. Mol. Biol. 42:1992;79-106.
15. Hall W.A., Flores E.P., Low W.C. Antisense oligonucleotides for central nervous system tumours. Neurosurgery. 38:1996;376-383.
16. M. Heilig, K.-H. Schlingensiepen, Antisense oligodeoxynucleotides as novel neuropharmacological tools for selective expression blockade in the brain, in: Genetic Manipulation of the Nervous System, Academic Press, 1996, pp. 249-268.
17. Johansen F.F., Diemer N.H. Enhancement of GABA neurotransmission after cerebral ischemia in the rat reduces loss of hippocampal CA1 pyramidal cells. Acta Neurol. Scand. 84:1991;1-6.
18. A receptor γ2 subunit subtype. Eur. J. Pharmacol. Mol. Pharmacol. 291:1995;439-441.
19. A receptor γ2 subunit induces loss of neurones in rat hippocampus. Neurosci. Lett. 202:1995;97-100.
20. A receptors, Neurochem. Int., (1996) in press.
21. Keilhoff G., Wolf G., Stastny F., Schmidt W. Quinolinate neurotoxicity and glutamatergic structures. Neuroscience. 34:1990;235-242.
22. Köhler C., Schwarcz R. Comparison of ibotenate and kainate neurotoxicity in rat brain: a histological study. Neuroscience. 8:1983;819-835.
23. Krieg A.M., Stein C.A. Phosphorothioate oligodeoxynucleotides: antisense or anti-protein? Antisense Res. Dev. 5:1995;241.
24. Krieg A.M., Yi A.-K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
25. Leonetti J.P., Degols G., Clarenc J.P., Mechti N., Lebleu B. Cell delivery and mechanisms of action of antisense oligonucleotides. Prog. Nucleic Acid Res. Mol. Biol. 44:1993;143-166.
26. A receptor channels. Annu. Rev. Neurosci. 17:1994;569-602.
27. 67 mRNAs modulate reproductive behavior in the female rat. Brain Res. 636:1994;209-220.
28. A receptor subtypes really occur in the brain? Trends Neurosci. 19:1996;139-143.
29. 2 subunit determines benzodiazepine efficacy. J. Biol. Chem. 209:1994;32768-32773.
30. A receptor function J. Pharmacol. Exp. Ther. 246:1988;170-176.
31. Möhler H., Okada T., Enna S.J. Benzodiazepine and neurotransmitter binding in rat brain after chronic administration of diazepam and phenobarbital. Brain Res. 156:1978;391-395.
32. Nielsen M., Braestrup C. The apparent target size of rat benzodiazepine receptor, acetylcholinesterase, and pyruvate kinase is highly influenced by experimental conditions. J. Biol. Chem. 263:1988;11900-11906.
33. Pilowsky P.M., Suzuki S., Minson J.B. Antisense oligonucleotides: a new tool in neuroscience. Clin. Exp. Pharmacol. Physiol. 21:1994;935-944.
34. A receptor subunit for benzodiazepine pharmacology. Nature. 338:1989;582-585.
35. Rosenberg H.C., Chiu T.H. Tolerance during chronic benzodiazepine treatment associated with decreased receptor density. Eur. J. Pharmacol. 70:1981;453-460.
36. Schwartz R.D., Yu X., Katzman M.R., Hayden-Hixson D.M., Perry J.M. Diazepam, given postischemia, protects selectively vulnerable neurons in the rat hippocampus and striatum. J. Neurosci. 15:1995;529-539.
37. A receptor subunits exist in distinct neuronal subpopulations. Neuron. 3:1989;327-337.
38. A receptor subtypes. Pharmacol. Rev. 47:1995;181-234.
39. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 42:1994;1-32.
40. Stein C.A. Does antisense exist? Nature Med. 1:1995;1119-1121.
41. Stein C.A., Cheng Y.-C. Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science. 261:1993;1004-1012.
42. Stein C.A., Krieg A.M. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides (Editorial). Antisense Res. Dev. 4:1994;67-69.
43. A receptors. Biochem. J. 310:1995;1-9.
44. Wagner R.W. Gene inhibition using antisense oligodeoxynucleotides. Nature. 372:1994;333-335.
45. Wahlestedt C. Antisense oligonucleotide strategies in neuropharmacology. Trends Pharmacol. Sci. 15:1994;42-46.
46. Wahlestedt C., Golanov E., Yamamoto S., Yee F., Ericson H., Yoo H., Inturrisi C.E., Reis D.J. Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature. 363:1993;260-263.
47. Weiss B., Zhou L.-W., Zhang S.-P., Qin Z.-H. Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA. Neuroscience. 55:1993;607-612.
48. Whitesell L., Geselowitz D., Chavany C., Fahmy B., Walbridge S., Alger J.R., Neckers L.M. Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system. Proc. Natl. Acad. Sci. USA. 90:1993;4665-4669.
49. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon J. Neurosci. 12:1992;1040-1062.
50. Yaida Y., Nowak T.S. Jr. Distribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventricular and intrahippocampal administration determined by in situ hybridization. Regul. Pept. 59:1995;193-199.
51. 2 receptors: behavioral correlates. Neurosci. Lett. 161:1993;223-226.
52. A receptor γ2 subunit increases convulsive threshold for β-CCM, a benzodiazepine 'inverse agonist', in rats. Eur. J. Pharmacol. 306:1996;61-66.
53. Zhu W.J., Wang J.F., Vicini S., Grayson D.R. α6 and γ2 subunit antisense oligodeoxynucleotides alter γ-aminobutyric acid receptor pharmacology in cerebellar granule neurons. Mol. Pharmacol. 50:1996;23-33.